To the full analysis
Hims & Hers Health stock: growth
HIMSHims & Hers Health reported $2.35B in revenue for fiscal 2025, up 59% on the prior year, up 73.6% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
74.7%
per year from 2019 to 2025, per share 28%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2019 | |
|---|---|---|
| Revenue | 73.6% | 74.7% |
| Revenue per share | 19.9% | 28.0% |
| Earnings | no data | no data |
| Earnings per share | no data | no data |
| Free cash flow | no data | no data |
| Free cash flow per share | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2019 | $82.56M | −$72.06M | −$76.65M |
| 2020 | $148.76M | −$18.11M | −$6.71M |
| 2021 | $271.88M | −$107.66M | −$39.42M |
| 2022 | $526.92M | −$65.68M | −$33.78M |
| 2023 | $872M | −$23.55M | $46.99M |
| 2024 | $1.48B | $126.04M | $198.33M |
| 2025 | $2.35B | $128.37M | $73.96M |
Revenue by region
Where Hims & Hers Health, Inc. generates its revenue.
- United States$2.2B94%
- Outside the US$134.0M6%
The company split earlier years differently. A history would not be comparable, so only 2025 is shown.
Figures as a table
| 2025 | Share 2025 | |
|---|---|---|
| United States | $2.21B | 94.3% |
| Outside the US | $133.99M | 5.7% |
| Total revenue | $2.35B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 15 May 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.